| Authors | Title | Journal | Volume | Publication Date |
|---|---|---|---|---|
| Cisnetto, V., Barlow, J. | The development of complex and controversial innovations. Genetically modified mosquitoes for malaria eradication | Research Policy | April 2020 | |
| Ni, M., Borsci, S., Walne, S., Mclister, A.P., Buckle, P., Barlow, J.G., Hanna, G.B. | The Lean and Agile Multi-dimensional Process (LAMP) - a new framework for rapid and iterative evidence generation to support health-care technology design and development. | Expert Review Of Medical Devices | March 2020 | |
| Goiana-da-Silva, F., Severo, M., Cruz E Silva, D., Gregorio, M.J., Allen, L.N., Muc, M., Morais Nunes, A., Torres, D., Miraldo, M., Ashrafian, H. | Projected impact of the Portuguese sugar-sweetened beverage�tax on obesity incidence across different age groups: A�modelling study | Plos Medicine | March 2020 | |
| Ochalek, J., Manthalu, G., Smith, P.C. | Squaring the cube: Towards an operational model of optimal universal health coverage | Journal Of Health Economics | March 2020 | |
| Janke, K., Johnston, D.W., Propper, C., Shields, M.A. | The causal effect of education on chronic health conditions in the UK | Journal Of Health Economics | March 2020 | |
| Isaranuwatchai, W., Teerawattananon, Y., Archer, R.A., Luz, A., Sharma, M., Rattanavipapong, W., Anothaisintawee, T., Bacon, R.L., Bhatia, T., Bump, J. | Prevention of non-communicable disease: best buys, wasted buys, and contestable buys | Bmj-british Medical Journal | January 2020 | |
| Thomas, R., Skovdal, M., Galizzi, M.M., Schaefer, R., Moorhouse, L., Nyamukapa, C., Maswera, R., Mandizvidza, P., Hallett, T.B., Gregson, S. | Improving risk perception and uptake of voluntary medical male circumcision with peer-education sessions and incentives, in Manicaland, East Zimbabwe: Study protocol for a pilot randomised trial | Trials | January 2020 | |
| Heard, J-M., Vrinten, C., Schlander, M., Bellettato, C.M., van Lingen, C., Scarpa, M., Matthijs, G., Nassogne, M-C., Debray, F-G., Roland, D. | Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network | Orphanet Journal Of Rare Diseases | January 2020 |